Agitation control with clonidine and haloperidol in critically ill patients: A retrospective analysis

Area of Science:

• Critical Care Medicine
• Pharmacology
• Patient Management

Background:

• Agitation is common in intensive care units (ICUs), requiring effective pharmacological management.
• Clonidine and haloperidol are used for agitation control, but their comparative efficacy and impact on other sedatives are not fully elucidated.

Purpose of the Study:

• To compare the effectiveness of clonidine, haloperidol, and their combination in controlling agitation in ICU patients.
• To assess the impact of these agents on the usage of other sedatives and analgesics.

Main Methods:

• A cohort study analyzed 510 agitation episodes in 247 mixed ICU patients.
• Propensity score matching and Markov multinomial logistic regression were used to evaluate agitation control (Richmond Agitation Sedation Scale [RASS] score -2 to 1).
• Concomitant medication use, including propofol and opioids, was explored.

Main Results:

• No significant difference in agitation control was observed between clonidine alone, haloperidol alone, or combination therapy.
• Haloperidol alone and combination therapy were associated with reduced propofol usage compared to clonidine alone.
• Combination therapy was linked to decreased opioid requirements, with no change in benzodiazepine administration.

Conclusions:

• Clonidine, haloperidol, and their combination do not differ in their ability to control ICU agitation.
• Combination therapy may allow for reduced use of propofol and opioids in agitated ICU patients.